Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to $2.4 million.

  • Avidity Biosciences' Amortizatization of Intangibles fell 6487.0% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 391.03%. This contributed to the annual value of $21.4 million for FY2024, which is 9023.42% up from last year.
  • As of Q3 2025, Avidity Biosciences' Amortizatization of Intangibles stood at $2.4 million, which was down 6487.0% from $3.5 million recorded in Q2 2025.
  • Avidity Biosciences' 5-year Amortizatization of Intangibles high stood at $7.2 million for Q4 2024, and its period low was -$40000.0 during Q1 2021.
  • In the last 5 years, Avidity Biosciences' Amortizatization of Intangibles had a median value of $2.4 million in 2025 and averaged $2.5 million.
  • As far as peak fluctuations go, Avidity Biosciences' Amortizatization of Intangibles skyrocketed by 878888.89% in 2021, and later tumbled by 6487.0% in 2025.
  • Avidity Biosciences' Amortizatization of Intangibles (Quarter) stood at $782000.0 in 2021, then decreased by 12.92% to $681000.0 in 2022, then soared by 375.33% to $3.2 million in 2023, then skyrocketed by 121.38% to $7.2 million in 2024, then plummeted by 66.44% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $3.5 million for Q2 2025, and $5.2 million during Q1 2025.